Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study.
暂无分享,去创建一个
B. Chaitman | E. Braunwald | G. Knatterud | N. Kleiman | R. Roberts | M. Terrin | H. Mueller | R. Solomon | R. Mcmahon | E. Braunwald | Neal S Kielman | Hiltrud S. Mueller | Robert Roberts | Robert P. McMahon
[1] H. Hellstrom. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. , 1991, Circulation.
[2] W. Rogers,et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.
[3] B. Rutherford,et al. Results of primary angioplasty for acute myocardial infarction in patients with multivessel coronary artery disease. , 1990, Journal of the American College of Cardiology.
[4] R. Califf,et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. , 1990, Circulation.
[5] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction , 1990, The Lancet.
[6] J. Gore,et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. , 1990, Circulation.
[7] P. Morand,et al. [Treatment of primary cardiogenic shock by coronary transluminal angioplasty during the acute phase of myocardial infarction]. , 1990, Archives des maladies du coeur et des vaisseaux.
[8] U. Tebbe,et al. Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. , 1989, Journal of the American College of Cardiology.
[9] E. Topol,et al. Coronary angioplasty as primary therapy for acute myocardial infarction 6 to 48 hours after symptom onset: report of an initial experience. , 1989, Journal of the American College of Cardiology.
[10] W. O’Neill,et al. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. , 1988, Circulation.
[11] H. Sather,et al. INTENSIVE THERAPY FOR CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKAEMIA AND UNFAVOURABLE PRESENTING FEATURES Early Conclusions of Study CCG-106 by the Childrens Cancer Study Group , 1988, The Lancet.
[12] A. M. Skene,et al. TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION Anglo-Scandinavian Study of Early Thrombolysis (ASSET) , 1988, The Lancet.
[13] T. Meinertz,et al. The German multicenter trial of anisoylated plasminogen streptokinase activator complex versus heparin for acute myocardial infarction. , 1988, The American journal of cardiology.
[14] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[15] E. Braunwald,et al. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. , 1988, The American journal of cardiology.
[16] H. Lambertz,et al. THROMBOLYSIS WITH TISSUE PLASMINOGEN ACTIVATOR IN ACUTE MYOCARDIAL INFARCTION: NO ADDITIONAL BENEFIT FROM IMMEDIATE PERCUTANEOUS CORONARY ANGIOPLASTY , 1988, The Lancet.
[17] E. B. Carlson,et al. Coronary perfusion during acute myocardial infarction with a combined therapy of coronary angioplasty and high-dose intravenous streptokinase. , 1988, Circulation.
[18] K. Lee,et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. , 1987, The New England journal of medicine.
[19] D. Rothbaum,et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. , 1987, Journal of the American College of Cardiology.
[20] R Roberts,et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. , 1987, Circulation.
[21] Harold T. Dodge,et al. Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase* , 1987 .
[22] M. Franzosi,et al. [The Italian Group for the Study of Streptokinase in Myocardial Infarct: Analysis of intrahospital causes of death]. , 1987, Giornale italiano di cardiologia.
[23] Y. Ohtsuki,et al. ISOLATION OF HTLV-I FROM CEREBROSPINAL FLUID OF A PATIENT WITH MYELOPATHY , 1986, The Lancet.
[24] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[25] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[26] H. Morgenstern,et al. Epidemiologic Research: Principles and Quantitative Methods. , 1983 .
[27] B. Sobel,et al. Progressive nature of myocardial injury in selected patients with cardiogenic shock. , 1978, The American journal of cardiology.
[28] T. Waterston. Fluids for diarrhoea in young children. , 1977, Lancet.
[29] H. Galperin-Lemaître,et al. ULTRASOUND AND SAFETY , 1976, The Lancet.
[30] E. Veys,et al. Letter: HL-A and infective sacroileitis. , 1974, Lancet.
[31] J. Fleiss,et al. Statistical methods for rates and proportions , 1973 .
[32] T. Killip,et al. Pathophysiology of Cardiogenic Shock: Quantification of Myocardial Necrosis, Clinical, Pathologic and Electrocardiographic Correlations , 1973, Circulation.
[33] S. Gilder. Home or Away. , 1964, Canadian Medical Association journal.
[34] J. Sebus,et al. THE SIMIAN CREASE. , 1964, Lancet.
[35] Brain Wr,et al. Mind and matter. , 1951 .